Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Operating activities:
Net income (loss)	$ (8,001)	$ (14,230)	$ 17,141
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deferred taxes	(3,566)	(7,620)	(1,073)
Noncash deferred tax asset charge	0	0	3,190
Amortization of stock-based compensation	2,260	3,090	2,803
Distributions of earnings from unconsolidated joint ventures	374	715	1,588
Inventory impairments	10,200	10,000	2,200
Abandoned project costs	94	206	383
Equity in net (income) loss of unconsolidated joint ventures	3,503	19,653	(866)
Deferred profit from unconsolidated joint ventures	0	136	821
Depreciation and amortization	8,957	6,631	449
Gain on early extinguishment of debt	(1,164)	0	0
Net changes in operating assets and liabilities:
Contracts and accounts receivable	2,283	4,959	4,670
Due from affiliates	930	(242)	18
Real estate inventories	123,239	(157,705)	(114,930)
Other assets	(2,326)	(11,642)	(5,255)
Accounts payable	(14,347)	15,669	(9,546)
Accrued expenses and other liabilities	(1,178)	(9,305)	7,544
Net cash provided by (used in) operating activities	121,258	(139,685)	(90,863)
Investing activities:
Purchases of property and equipment	(41)	(246)	(195)
Cash assumed from joint venture at consolidation	0	0	995
Contributions and advances to unconsolidated joint ventures	(8,826)	(15,066)	(27,479)
Distributions of capital and repayment of advances from unconsolidated joint ventures	9,133	15,436	15,577
Interest collected on advances to unconsolidated joint ventures	0	178	552
Net cash provided by (used in) investing activities	266	302	(10,550)
Financing activities:
Borrowings from credit facility	50,000	150,000	88,000
Repayments of credit facility	(117,500)	(82,500)	(206,000)
Proceeds from senior notes	0	0	324,465
Repurchases of senior notes	(15,605)	0	0
Repayments of other notes payable	0	0	(4,110)
Payment of debt issuance costs	0	0	(7,565)
Repurchases of common stock	(1,042)	(8,563)	0
Tax withholding paid on behalf of employees for stock awards	(488)	(982)	(590)
Proceeds from exercise of stock options	0	0	102
Net cash (used in) provided by financing activities	(84,635)	57,955	194,302
Net increase (decrease) in cash, cash equivalents and restricted cash	36,889	(81,428)	92,889
Cash, cash equivalents and restricted cash – beginning of year	42,542	123,970	31,081
Cash, cash equivalents and restricted cash – end of year	$ 79,431	$ 42,542	$ 123,970